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Jugular bulb desaturation during rewarming from cardiopulmonary bypass is influenced by
isoflurane
MJA Robson, RP Alston, PJD Andrews and MJ Souter
Department of Anaesthetics, Royal Infirmary of Edinburgh, Edinburgh, Scotland
Introduction: Jugular bulb oxyhaemoglobin desaturation
(SjO2 ≤ 50%) during the rewarming phase of cardiopul-
monary bypass (CPB) is associated with postoperative
cognitive deficits [1]. Isoflurane effects cerebral blood
flow and cerebral metabolic rate, both of which affect
SjO2 [2]. We report the effect of isoflurane on the inci-
dence of desaturation during rewarming from CPB for
coronary artery surgery.
Materials and methods: One hundred and nine men and
16 women of mean age 60 years (standard deviation 9
years) were studied. Isoflurane 1% was used on CPB for
hypnosis in 61 patients and 64 received either propofol or
a combination of morphine and midazolam. A catheter was
positioned in the right jugular bulb. At 36°C, during
rewarming, paired jugular bulb and arterial samples were
taken for blood gas and SjO2 measurements. Nasopharyn-
Table 1
Blood gas and blood pressure results
I group (n = 61) NI group (n = 64) P
SjO2 (%) 64.6 (9.5) 58.3 (11.6) 0.001
SjO2 carbon dioxide corrected (%) 70.6 (8.4) 63.5 (10.7) 0.001
SjO2 ≤50% (n) 3 (4.9%) 16 (25%) <0.01
SjO2 ≤50% carbon dioxide corrected (n) 1 (1.6%) 3 (4.7%) >0.2
PaCO2 (kPa) 4.49 (0.55) 4.59 (0.54) 0.286
MAP (mmHg) 58.8 (15.2) 64.5 (15.6) 0.065
Haemoglobin (g/dl) 8.3 (0.98) 8.6 (1.2) 0.258
SaO2 (%) 98.0 (0.6) 98.0 (0.5) 0.948
CPB (min) 88 (24) 86 (34) 0.661
Min temp CPB (°C) 31.0 (2.0) 30.9 (1.8) 0.797
Rewarm rate (°C/min) 0.21 (0.08) 0.26 (0.09) 0.001
Values are expressed as mean (standard deviation), unless otherwise indicated. CPB, cardiopulmonary bypass; I, isoflurane; MAP, mean arterial
pressure; NI, morphine and midazolam; PaCO2, arterial carbon dioxide tension; SaO2, arterial oxygen saturation; SjO2, oxyhaemoglobin
desaturation.
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geal temperature was measured throughout. SjO2 values
were analyzed as measured and also after correction to an
arterial carbon dioxide tension of 5.3 kPa. The number of
patients who desaturated in each group was analyzed by
χ2 test and the mean differences in the variables by Stu-
dent’s t-test.
Results: Blood gas and blood pressure results are sum-
marised in Table 1. Correcting for carbon dioxide signifi-
cantly reduced the number of patients who desaturated in
the morphine and midazolam group (25–4.7%, χ2 = 10.4;
P < 0.01) but not the isoflurane group (4.9–1.6%;
P > 0.2).
Conclusion: The incidence of desaturation during
rewarming was significantly reduced by isoflurane. This
suggests the balance between cerebral blood flow and
cerebral metabolic rate during the rewarming phase of
CPB is better preserved in the presence of isoflurane. Dif-
ferent arterial carbon dioxide tension levels cannot explain
this effect, but the rate of rewarming may be one factor.
Whether prevention of desaturation by isoflurane improves
cognitive outcome is yet to be determined.
Acknowledgement: Funded by Wellcome Trust grant
050190.
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Can extubation time be predicted?
A Macfie, L Anderson, KH McKinlay and J Nicol
Department of Anaesthesia, Western Infirmary, Dumbarton Road, Glasgow, Scotland
Introduction: Fast-tracking has become an established
practice in many cardiac units. We have attempted to
identify the factors that may result in prolonged ventilation
in our unit.
Materials and methods: The audit was conducted
prospectively over an 8-week period during February and
March 1999. The audit forms of a total of 156 patients
who passed through the intensive care unit were analyzed.
Appropriate criteria for extubation were set out before-
hand, as were guidelines for management of pain, shiver-
ing, agitation and confusion, and poor gas exchange. The
following data was collected: patient details; operation,
anaesthetist and surgeon; anaesthetic technique; preoper-
ative risk stratification (Parsonnet and Euro-scores); time
to extubation; principal reason for continued ventilation
(recorded every 2 h for 24 h); and hospital discharge date.
Results: The patients were divided into four principal
groups according to their extubation times: less than 6 h,
6–12 h, 12–24 h and longer than 24 h. We focused partic-
ularly on the group of patients with extubation times less
than 6 h and found that 25.7% were extubated during this
period (as compared with only 3% from previous audit
figures in 1997). Neither the Parsonnet or Euroscore pre-
dicted extubation times well. The percentage of patients
extubated in under 6 h divided into low, medium and high
risk groups for Parsonnet were 29.3, 15.15 and 34.6%,
and for Euroscore 26.5, 29.3 and 16.7%. Very high scores
were associated with longer ventilation times as expected.
The percentage of patients in the less than 6 h group was
found to vary between individual anaesthetists from 8.0 to
50% and surgeons 7.7–31.6%. This degree of variation
could not be explained by preoperative risk stratification
alone. Patients first on the theatre list (am) were more
likely to be extubated within 6 h (32.1%) compared with
patients who were later on the list (pm; 18.2%; P < 0.05).
This could not be explained by risk stratification. Of ‘am
patients’ 74.1% were discharged by day 6 compared with
60% of ‘pm patients’ (P = 0.08). When we examined the
effects of coexistent disease we found that smoking had
little effect (25.8% <6 h), presence of chronic obstructive
pulmonary disease delayed extubation (16.7%) and exces-
sive alcohol intake appeared to expedite extubation
(37.5%) compared with all patients (25.6%), but these
associations did not reach statistical significance. The
drugs used to provide hypnosis and analgesia on car-
diopulmonary bypass were recorded, and the percentage
of patients extubated in under 6 h were as follows: mida-
zolam 13.7%, volatile on bypass 16.1%, propofol infusion
30.3% and methohexitone 44.4%, remifentanil 14.3%,
fentanyl 25.0% and alfentanil 38.5%. The common causes
of continued ventilation at 6 h were ‘too drowsy’ (70%)
and ‘poor gases’ (28%), but at 24 h were ‘inotropic
support’ (86%), ‘confusion’ (43%) and the use of ‘intra-
aortic balloon pump’ (37%) were cited by the attending
nurse. The percentages of patients discharged by the sixth
postoperative day were 80.0% in the less than 6 h group,
70.6% in the 6–12 h group, 57.6% in the 12–24 h group
and 0.0% in the longer than 24 h group (P < 0.05).
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Conclusion: Early extubation may expedite recovery and
hospital discharge. Extubation time was influenced by
both anaesthetist and the anaesthetic technique used.
Current preoperative risk scoring systems are insensitive
predictors of ventilation times. Patients that had their oper-
ations later in the day were more likely to be ventilated
overnight, perhaps unnecessarily. Clinical audit changes
practice and can be a very useful tool.
A comparison of sequential total and activated white cell count in patients undergoing coronary
artery bypass grafting, using cardiopulmonary bypass, with and without a white cell filter
JK Nanson, SV Sheppard, M Kulkarni and DC Smith
Shackleton Department of Anaesthetics, Southampton General Hospital, Southampton, UK
Introduction: Cardiopulmonary bypass (CPB) has been
shown to induce a systemic inflammatory response similar
to the local reaction seen after tissue damage [1]. This
leads to the release of toxic substances, such as elastase,
which cause endothelial damage and may adversely affect
outcome [2]. Use of a leucocyte depleting arterial line filter
is one of many anti-inflammatory strategies that are under-
going evaluation. Leucocyte depleting filters may be
capable of selectively removing activated white cells [3],
but this has not been proved in vivo. The aim of the
present study was to compare sequential total and acti-
vated white cells during CPB, using either a leucocyte
depleting or standard arterial line filter.
Materials and methods: After local ethical committee
approval, 20 patients undergoing coronary artery
bypass grafting using CPB were prospectively ran-
domly allocated to have either a Leukogard LG-6 (Pall
Biomedical, Portsmouth, UK) or a nonleucocyte deplet-
ing filter inserted into the arterial line of the CPB circuit.
Arterial limb blood samples were taken immediately
after institution of CPB (0 min) and at 10-min intervals
throughout the bypass period. Activated white cells
were identified using nitroblue tetrazolium, then both
total and activated white cell numbers counted after
staining with Leucoplate.
Results: Table 2 shows the number of white cells
counted/1.25 µl (volume of a single channel of Nageotte
counting chamber) using light microscopy (× 25).
Conclusion: The LG6 leucocyte filter reduces the total
white cell count and is capable of selectively removing
activated white cells during CPB. The exact relationship
between leucocyte depletion and improved patient
outcome still remains unclear.
Table 2
Mean total and activated white cell counts
NLDF control group LG6 filter study group
Time (min) Mean total WCC (range) Activated WCC (range) Mean total WCC (range) Activated WCC (range)
0 684 (282–1155) 38 (1–328) 417 (253–531) 5 (2–8)
10 680 (260–1384) 37 (1–318) 351 (283–478) 4 (1–18)
20 767 (260–1684) 21 (2–152) 335 (222–526) 4 (0–20)
30 798 (305–1572) 54 (1–477) 294 (195–796) 5 (1–24)
40 900 (372–1802) 33 (2–266) 420 (302–709) 5 (1–20)
50 948 (277–1911) 50 (2–302) 490 (251–672) 7 (1–18)
60 969 (433–1707) 58 (2–351) 545 (403–740) 5 (0–14)
70 746 (500–1233) 11 (1–18) 587 (525–650) 7 (6–9)
80 662 (548–762) 12 (2–20) 541 6
90 847 (656–1038) 9 (5–12) – –
100 732 6 – –
NLDF, nonleucocyte depleting filter; WCC, white cell count.
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Correlation between preoperative platelet levels and heparin response
AB Ahmed, RJ Mills, AE Crosbie, TI Burns, RD Latimer and A Vuylsteke
Department of Anaesthesia, Papworth Hospital, Cambridge, UK
Introduction: Identification of factors responsible for the
development of reduced sensitivity to heparin have impor-
tant implications for cardiac surgery with cardiopulmonary
bypass, because inadequate anticoagulation during this
procedure can have profound thrombotic and haemor-
rhagic consequences. Recently, it was noted [1,2] that
preoperative platelet levels are higher in heparin-resistant
patients than in those who are heparin sensitive. In the
present study, a possible relationship between preopera-
tive platelet levels and heparin response was investigated.
Materials and methods: After local regional ethics com-
mittee approval and patients’ informed consent was
obtained, 87 patients undergoing either coronary artery
bypass surgery (n = 73), valvular surgery (n = 8) or a com-
bination of both (n = 6) were studied. Both preoperative
platelet count and the heparin dose response (HDR)
[measured using the Hepcon Hemostasis Management
System (Medtronic, USA)] were determined for each
patient. Patients with an HDR slope of 80 s/unit heparin
per ml of blood or less were considered to have a reduced
heparin sensitivity and were studied further. Heparin
administration was standardized in all patients and coagu-
lation status was determined by measuring the activated
clotting time (ACT). If an ACT of 480 s or greater was not
achieved after administration of 300 U/kg heparin, then a
further 100 U/kg was given. Patients were considered
heparin resistant if the ACT was 480 s or less after the
second heparin dose. Patient data were compared using
the Mann-Whitney U-test with results expressed as
median (interquartile range) where appropriate. Correla-
tion analysis was by Spearman’s rank sum correlation.
Results: From the original 87 patients, 30 had an HDR
slope of greater than 80 s/U per ml (group 1). From the
remaining 57 patients, 42 had an ACT of 480 s or greater
after the first heparin dose (group 2), eight had an ACT of
480 s or greater after the additional heparin dose (group
3) and seven were considered to be heparin resistant
(group 4). A significant correlation was measured between
preoperative platelet levels and a reduced sensitivity to
heparin (measured by the HDR slope; P < 0.001). No cor-
relation with preoperative platelet levels was determined
for either the baseline ACT or the ACT after the first
heparin dose. Preoperative platelet count was shown to
be significantly higher in groups 3 [252 (221–270) ×
109/l) and 4 [262 (222–314) × 109/l), compared with
194 (165–223) × 109/l in group 1 (P < 0.05).
Conclusion: Preoperative platelet levels have been shown
to correlate with a reduced sensitivity to heparin. This can
probably be explained by the fact that patients with a
higher platelet count have a greater capacity to produce
platelet factor-4, which is released when platelet aggrega-
tion takes place. This mediator has a heparin neutralizing
effect. We conclude therefore that assessment of preop-
erative platelet levels might be a useful diagnostic tool in
identifying patients who have a reduced sensitivity to
heparin.
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Coagulation and neonatal bypass: an assessment of changes in coagulation factor concentration
during cardiopulmonary bypass in neonates, with modified ultrafiltration
P Arnold, S Jackson, D Bolton, J Smith and S Haynes
Department of Cardiothoracic Anaesthesia, Freeman Hospital, Newcastle Upon Tyne, UK
Introduction: Bleeding is of major concern in neonates
after cardiopulmonary bypass. More severe coagulopathy
can be expected in children who weigh under 8 kg. The
effect of cardiopulmonary bypass on factor concentration
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has been described previously using a prime of fresh
whole blood. Fresh whole blood is not generally available
in the UK. In addition we describe the effect of modified
haemofiltration and changes in factor V concentration,
which has not previously been described.
Materials and methods: Ethical approval was gained and
consent was obtained from the patient’s parents. An
observational design was adopted for the present study.
Cardiopulmonary bypass was conducted as is routine at
the Freeman Hospital. The pump prime had an average
volume of 900 ml. This consisted of one unit of fresh
frozen plasma, packed cell to target haematocrit of 25%,
sodium bicarbonate, heparin, and a balanced crystalloid
solution. All patients were subjected to extreme hypother-
mia (17–21°C), received heparin (3 mg/kg) and protamine
reversal, and received modified ultrafiltration after separa-
tion from bypass. Blood samples were taken before
bypass, on full flow, at minimum temperature, after
rewarming, after modified ultrafiltration and on return to
intensive care. The samples were analyzed for haemoglo-
bin, platelets, standard coagulation tests and colloid
osmotic pressure. The samples were stored for analysis of
factors II, V, VII, VIII, IX and X, antithrombin III, and markers
of activation (TAT, PTf 1+2, D-dimers).
Results: Fourteen patients were recruited (age 3–21
days). Thirteen patients had arterial switch procedures,
one patient had repair of an interrupted aortic arch.
Weights were 2.2–4.4 kg.
Before bypass most levels were at the low end of the
expected range for neonates of this age. After initiation of
bypass, factor concentrations fell to extremely low levels.
With the exception of factors V and VII, the change was
predictable from the degree of haemodilution with the
pump prime. Factor V levels fell to less than 50% of pre-
dicted activity. During hypothermic bypass there was little
change in factor activity or evidence of blood activation.
After discontinuation of bypass and modified ultrafiltration,
factor concentrations rose to an unpredictable degree.
Although factor V activity increased by almost 200%,
platelet counts rose by only 4%. In addition there was evi-
dence of marked activation at this stage with increases in
TAT, PTf 1+2, and D-dimers levels. On return to intensive
care factors V and VIII levels were below the expected
range in the majority of patients (11 and 7 patients,
respectively). Fibrinogen levels were below age normal in
eight patients, but were greater than 0.5 g/dl in all but one.
Discussion: The low levels of factor V on bypass are of
interest. Further work has demonstrated that loss of factor
V occurs as soon as the FFP is added to the circuit
(without connection to the patient). This suggests absorp-
tion into the circuit plastics.
The factor deficiencies during bypass are profound but
predictable. The increase after ultrafiltration points to a
further advantage of this technique, but evidence of
platelet consumption is a concern. Continuing deficiencies
of factors VIII and V may add to bleeding postoperatively.
Factor V concentrate is not available.
Effects of clomethiazole on neuropsychological outcome following coronary artery bypass graft
surgery
RS Kong, W Aveling, J Butterworth*, D Stump*, MJG Harrison and S Newman
Middlesex Hospital and University College London Medical School, London, UK, and *Wake Forest University School of
Medicine, North Carolina, USA
Introduction: The γ-aminobutyric acid A receptor agonist
clomethiazole has been shown to have neuroprotective
properties in animal models of global and focal brain
ischaemia. In the present study we investigated the effi-
cacy of clomethiazole in improving neuropsychological
outcome after coronary artery bypass surgery.
Materials and methods: Two hundred and forty-five
patients scheduled for coronary artery bypass surgery
were prospectively randomized at two centres to intra-
venous clomethiazole edisilate (8 mg/ml) or placebo (0.9%
sodium chloride) in a double-blind trial. The drug was
infused after induction of anaesthesia and continued until
the end of surgery. Coronary artery grafting was com-
pleted during mild-to-moderate hypothermia (28–32°C)
cardiopulmonary bypass. Baseline neuropsychological
assessment was made the day before surgery, using a
battery of eight tests, and repeated 4–7 weeks after
surgery. Neuropsychological outcome was evaluated by
two methods: postoperative change compared with base-
line of a global test score, which combined the scores
from the eight tests; and the change in individual test
scores after surgery compared with baseline.
Results: Neuropsychological assessments were com-
pleted in 219 patients (110 clomethiazole and 109
placebo). The mean age in both groups was 64.5 years
(range 50–84 years) with a male sex distribution of 89%
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in the clomethiazole and 76% in the placebo group. There
was no difference between the two groups in the change
before and after surgery of either the global or individual
test scores.
Conclusion: Clomethiazole was not found to influence
neuropsychological outcome in patients undergoing coro-
nary artery surgery.
Funding: Astra Arcus AB, Sweden and Astra USA Inc
funded the project.
